De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents

AIM: Recent studies raise concerns for higher incidence of hepatocellular carcinoma (HCC) after direct-acting antiviral therapy for hepatitis C virus (HCV). METHODS: In this study, using analysis of liver imaging pre- and post-DAA treatment, we queried new occurrence or ‘de novo’ of HCC in patients...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepat Oncol
Egile Nagusiak: Kuftinec, Gabriela, Loehfelm, Thomas, Corwin, Michael, Durbin-Johnson, Blythe, Candido, MarieChristi, Hluhanich, Rebecca, Sarkar, Souvik
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168046/
https://ncbi.nlm.nih.gov/pubmed/30302197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2018-0003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak